IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH)

CUSIP: 23254X201

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Class A common stock, $0.001 par value
Shares outstanding
162,474,849
Total 13F shares
2,261,772
Share change
-15,681
Total reported value
$1,334,476
Price per share
$0.59
Number of holders
20
Value change
-$9,941
Number of buys
5
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 23254X201?
CUSIP 23254X201 identifies CYTH - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) as of Q4 2024

As of 31 Dec 2024, IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,261,772 shares. The largest 10 holders included EPIQ Capital Group, LLC, VANGUARD GROUP INC, Founders Fund V Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Founders Fund VI Management, LLC, BlackRock, Inc., TWO SIGMA SECURITIES, LLC, STATE STREET CORP, NORTHERN TRUST CORP, and WEALTH ENHANCEMENT ADVISORY SERVICES, LLC. This page lists 20 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.